Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Design, synthesis and biological evaluation of N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1.

Bioorg. Med. Chem.. 2019-05; 
GryshchenkoA A,BdzholaV G,BalandaA O,BriukhovetskaN V,KoteyI M,GolubA G,RubanT P,LukashL L,Yarmolu
Products/Services Used Details Operation
Peptide Synthesis The FGFR1 kinase assays with recombinant cytoplasmic domain of the FGFR1 tyrosine kinase (Millipore, Cat. N. 14-582) were performed in a total volume of 30 µl containing 10 mM MOPS (рН 7.2), 0.1 mM sodium orthovanadate, 0.2 mM EDTA, 0.002 % Brij 35, 0.2 mg/ml BSA, 0.02 % βmercaptoethanole, 250 mM of peptide substrate (KKKSPGEYVNIEFG, GenScript), various concentrations of inhibitor dissolved in DMSO (final DMSO concentration in probe less than 1%) and 7 ng of enzyme. Get A Quote

摘要

Fibroblast grow factor receptor 1 (FGFR1) is an important anti-cancer target that plays crucial role in oncogenesis and oncogenic angiogenesis. The structure-activity relationship (SAR) of N-phenylthieno[2,3-d]pyrimidin-4-amines was investigated. Binding of active compounds with FGFR1 kinase was analyzed by molecular modeling studies. Selected active thieno[2,3-d]pyrimidines were tested for selectivity and antiproliferative activity. The most active compounds, 3-({6-phenylthieno[2,3-d]pyrimidin-4-yl}amino)phenol and 3-({5-phenylthieno[2,3-d]pyrimidin-4-yl}amino)phenol have IC?? 0.16 and 0.18 μM, respectively. The results presented here may help to identify new thienopyrimidines with optimized cell ... More

关键词

Drug design,FGFR1 inhibitor,Molecular modeling,Thienopyrimid
XML 地图